Skip to content

Antibiotics and Activity Spaces: An Exploratory Study of Behaviour, Marginalisation, and Knowledge Diffusion

Antibiotics and Activity Spaces: An Exploratory Study of Behaviour, Marginalisation, and Knowledge Diffusion

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03241316
Acronym
ESRC
Enrollment
5885
Registered
2017-08-07
Start date
2017-01-01
Completion date
2018-10-31
Last updated
2018-11-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Antibiotic Use, Marginalisation (Economic, Social, Spatial), Rural Healthcare-seeking Behaviour

Keywords

qualitative and survey research

Brief summary

The investigators will conduct two rural surveys in Thailand and Lao PDR to improve the understanding of antibiotic-related health behaviour among the general population. One survey will capture a cross-section of health behaviours that is representative for the rural population in Chiang Rai (Thailand) and Salavan (Lao PDR), the other survey will create a two round village-level panel data set to study the evolution of health behaviours in the context of public engagement activities. The investigators will also collect complementary data about village-level infrastructure through observational check-lists, and collect secondary data on patient load from primary care units catering to their survey villages. As part of the questionnaire testing process, the investigators will conduct (and collect as primary data) cognitive interviews to improve the survey tool, to interpret their data, and to justify their methodological choices.

Detailed description

The investigators will collect two data sets each in Lao PDR and Thailand: the first contains district-level representative health behaviour of approx. 2,400 adults across 30 rural communities per country (4,800 in total; representing rural populations of approx. 1-2 million adults); the second is a complete social network census of approx. 1600 adults each in three rural communities per country (approx. 4,800 in total). Within the sampled villages, the investigators will complete checklists about existing formal and informal healthcare facilities and gather patient load data from primary care units catering to the respective villages. As part of the questionnaire testing process, the investigators will conduct (and collect as primary data) cognitive interviews to improve the survey tool, to interpret our data, and to justify our methodological choices. The investigators will carry out the district-level village survey in one round, and the village-level social network censuses in two rounds. Between the two village social network censuses, the investigators will engage in public engagement activities in the selected villages (focused on antibiotic use) and re-survey all adults in the three villages per country two to three months later. Objectives: The primary objective is to improve the understanding of patients' antibiotic-related behaviour to support creative thinking about targeted and unconventional antimicrobial resistance (AMR) interventions in low- and middle-income countries (LMICs). The investigators strive to achieve this primary objective by informing three research questions in Chiang Rai (Thailand) and Salavan (Lao PDR): 1. What are the manifestations and determinants of problematic antibiotic use in patients' healthcare-seeking pathways? 2. Will people's exposure to antibiotic awareness activities entail changed behaviours that diffuse or dissipate within a network of competing healthcare practices? 3. Which proxy indicators facilitate the detection of problematic antibiotic behaviours across and within communities?

Interventions

BEHAVIORALObservational study of behaviour

As a general population survey, our study does not involve a control group. Please note that the investigators do not interview patients; we involve only healthy members of the general public who consider themselves fit to be interviewed.

Sponsors

Mahidol Oxford Tropical Medicine Research Unit
CollaboratorOTHER
Economic and Social Research Council, United Kingdom
CollaboratorOTHER
Mae Fah Luang University
CollaboratorOTHER
University of Oxford
Lead SponsorOTHER

Study design

Observational model
ECOLOGIC_OR_COMMUNITY
Time perspective
OTHER

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Any villager in rural Chiang Rai (Thailand) or Salavan (Lao PDR) who had been sampled to participate in the survey * Is willing and able to give informed consent for participation in the study * Is aged 18 years and above

Exclusion criteria

* Respondent is not available or able to participate in interview after two attempts to arrange for appointment

Design outcomes

Primary

MeasureTime frameDescription
General population and villagelevel data on antibiotic access and use within individuals' healthcare-seeking pathwaysThe study is expected to take place from January 2017 to October 2018, with data collection scheduled for November 2017 to April 2018To improve the understanding of patients' antibiotic-related behaviour to support creative thinking about targeted and unconventional antimicrobial resistance (AMR) interventions in low- and middle-income countries (LMICs).

Secondary

MeasureTime frameDescription
Access to formal and informal medical treatmentThe study is expected to take place from January 2017 to October 2018, with data collection scheduled for April 2018.To understand the manifestations and determinants of problematic antibiotic use in patients' healthcare-seeking pathways.
Access to prescription and over-the-counter medicines including antibioticsThe study is expected to take place from January 2017 to October 2018, with data collection scheduled for April 2018.To understand the manifestations and determinants of problematic antibiotic use in patients' healthcare-seeking pathways.
Degree of technology use during the healthcare seeking processThe study is expected to take place from January 2017 to October 2018, with data collection scheduled for April 2018.To understand the manifestations and determinants of problematic antibiotic use in patients' healthcare-seeking pathways.
Awareness about rational antibiotic useThe study is expected to take place from January 2017 to October 2018, with data collection scheduled for April 2018.To understand the manifestations and determinants of problematic antibiotic use in patients' healthcare-seeking pathways.
Indicators of economic, social, and spatial marginalisationThe study is expected to take place from January 2017 to October 2018, with data collection scheduled for November 2017 to April 2018To understand the manifestations and determinants of problematic antibiotic use in patients' healthcare-seeking pathways.
Social network structures in rural communitiesThe study is expected to take place from January 2017 to October 2018, with data collection scheduled for April 2018.To understand whether people's exposure to antibiotic awareness activities entail changed behaviours that diffuse or dissipate within a network of competing healthcare practices.
Demand fluctuations for healthcare services over time within rural communitiesThe study is expected to take place from January 2017 to October 2018, with data collection scheduled for April 2018.To understand whether people's exposure to antibiotic awareness activities entail changed behaviours that diffuse or dissipate within a network of competing healthcare practices.
Proxy indicators that predict problematic antibiotic use in the general populationThe study is expected to take place from January 2017 to October 2018, with data collection scheduled for April 2018.To identify less data-intensive indicators to detect problematic contexts of antibiotic use
Typologies of desirable and undesirable healthcare practices with respect to antibiotic useThe study is expected to take place from January 2017 to October 2018, with data collection scheduled for April 2018.To understand whether people's exposure to antibiotic awareness activities entail changed behaviours that diffuse or dissipate within a network of competing healthcare practices.

Countries

Laos, Thailand

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 24, 2026